Melinia J Honjo, PA
Physician Assistant · Paradise Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Center for Dermatology PLLC · 69 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Melinia J Honjo’s office at (480) 771-1122 to ask if they take your plan before you enroll.
California Medical Board record
Licence C19717 · Cancelled
Licence status: Cancelled · since 1958 · University of Kansas School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$31,130
Medicare paid this office $31,130 for 152 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 101 | $8,432 | $56 |
| Destruction of skin growth, 1-14 growths | 41 | $3,206 | $67 |
| Destruction of precancer skin growth, 1 growth | 68 | $3,190 | $35 |
| Return visit (30+ min) | 31 | $2,447 | $70 |
| Biopsy of related skin growth, first growth | 41 | $2,348 | $55 |
See all 8 services
| Short return visit (20+ min) | 101 | $8,432 | $56 |
| Destruction of skin growth, 1-14 growths | 41 | $3,206 | $67 |
| Destruction of precancer skin growth, 1 growth | 68 | $3,190 | $35 |
| Return visit (30+ min) | 31 | $2,447 | $70 |
| Biopsy of related skin growth, first growth | 41 | $2,348 | $55 |
| Destruction of precancer skin growth, 2-14 growths | 57 | $1,418 | $4 |
| New patient visit (30+ min) | 17 | $1,094 | $64 |
| Short return visit | 13 | $518 | $37 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 15 | More than 70% of doctors who do this |
| Removal of skin lesions | 501 | More than 87% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 147 | More than 81% of doctors who do this |
Who their Medicare patients are
152 Original Medicare patients in 2024. Average age 75 · Under 65 0% · 85 and older 11% · Women 58% · Health risk score 0.87. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 63% · Coronary heart disease 26% · Diabetes 18% · Atrial fibrillation 18% · Depression 16% · Cancer 15% · Chronic kidney disease 11% · COPD 9% · Heart failure 8%.
The office billed $116,178, Medicare allowed $41,623 and paid $31,130; for 797 services of 29 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 152 | 797 | 75 | 0.87 | $116,178 | $31,130 |
| 2023 | 77 | 420 | 73 | 0.86 | $59,763 | $18,460 |
| 2022 | 22 | 97 | 74 | 1.38 | $11,300 | $4,519 |
| 2019 | 62 | 254 | 75 | 0.94 | $20,622 | $6,588 |
| 2018 | 66 | 239 | 76 | 1.02 | $22,328 | $8,561 |
| 2017 | 105 | 331 | 77 | 1.03 | $31,899 | $11,001 |
| 2016 | 117 | 362 | 77 | 0.88 | $40,193 | $14,202 |
| 2015 | 29 | 74 | 75 | 0.81 | $8,405 | $3,106 |
| 2013 | 21 | 102 | 78 | 1.57 | $13,861 | $5,245 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Short return visit (20+ min) | 41 | $3,745 | $65 |
| Return visit (30+ min) | 21 | $3,187 | $94 |
| Biopsy of related skin growth, first growth | 25 | $2,310 | $82 |
| Destruction of precancer skin growth, 1 growth | 36 | $2,290 | $46 |
| Destruction of skin growth, 1-14 growths | 15 | $1,632 | $86 |
| New patient visit (45+ min) | 12 | $1,149 | $96 |
| Destruction of precancer skin growth, 2-14 growths | 26 | $1,019 | $6 |
| New patient visit (15+ min) | 11 | $555 | $50 |
2022: 1 service
| Short return visit (20+ min) | 12 | $986 | $70 |
2019: 3 services
| Short return visit (20+ min) | 51 | $2,685 | $42 |
| Destruction of precancer skin growth, 1 growth | 22 | $949 | $32 |
| Destruction of precancer skin growth, 2-14 growths | 19 | $391 | $4 |
2018: 4 services
| Short return visit (20+ min) | 48 | $4,147 | $58 |
| Biopsy of single growth of skin and/or tissue | 17 | $1,493 | $88 |
| Destruction of precancer skin growth, 1 growth | 20 | $1,183 | $49 |
| Destruction of precancer skin growth, 2-14 growths | 16 | $274 | $4 |
2017: 5 services
| Short return visit (20+ min) | 72 | $4,856 | $53 |
| Destruction of precancer skin growth, 1 growth | 32 | $1,717 | $43 |
| Biopsy of single growth of skin and/or tissue | 21 | $1,612 | $77 |
| Short return visit | 14 | $584 | $31 |
| Destruction of precancer skin growth, 2-14 growths | 26 | $492 | $5 |
2016: 5 services
| Short return visit (20+ min) | 95 | $6,754 | $55 |
| Biopsy of single growth of skin and/or tissue | 25 | $2,016 | $81 |
| Destruction of precancer skin growth, 1 growth | 33 | $1,787 | $46 |
| New patient visit (15+ min) | 14 | $831 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 26 | $565 | $5 |
2015: 1 service
| Short return visit (20+ min) | 19 | $1,286 | $58 |
2013: 1 service
| Short return visit (20+ min) | 12 | $1,280 | $58 |
Drugs they prescribed that Part D paid
$5,044
Pharmacies billed $5,044 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 189) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
187 generic and fewer than 11 brand-name prescriptions · $5,044 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clobetasol Propionate | 19 | $1,420 | $75 |
| Imiquimod | 48 | $1,028 | $21 |
| Triamcinolone Acetonide | 20 | $241 | $12 |
| Ketoconazole | 16 | $170 | $11 |
| Mometasone Furoate | 11 | $144 | $13 |
See all 7 drugs
| Clobetasol Propionate | 19 | $1,420 | $75 |
| Imiquimod | 48 | $1,028 | $21 |
| Triamcinolone Acetonide | 20 | $241 | $12 |
| Ketoconazole | 16 | $170 | $11 |
| Mometasone Furoate | 11 | $144 | $13 |
| Hydroxyzine | 12 | $129 | $11 |
| Mupirocin | 12 | $70 | $6 |
Year by year
| 2024 | 189 | 95 | 0% (0) | None | $5,044 |
| 2023 | 57 | 26 | 0% (0) | None | $2,331 |
| 2022 | 21 | 12 | 0% (0) | 0% | $899 |
| 2020 | 44 | 14 | 0% (0) | None | $4,723 |
| 2019 | 169 | 55 | 0% (0) | 9% | $13,692 |
| 2018 | 181 | 59 | 0% (0) | 8% | $6,118 |
| 2017 | 153 | 67 | 0% (0) | None | $5,285 |
| 2016 | 124 | 57 | 0% (0) | None | $7,197 |
| 2015 | 118 | 50 | None | 15% | $11,445 |
| 2014 | 48 | 24 | 0% (0) | None | $4,986 |
| 2013 | 65 | 12 | None | 0% | $2,579 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 4 drugs
| Clobetasol Propionate | 13 | $622 | $48 |
| Ciclopirox | 11 | $500 | $45 |
| Hydroxyzine | 15 | $142 | $9 |
| Triamcinolone Acetonide | 14 | $111 | $8 |
2018: 5 drugs
| Clobetasol Propionate | 14 | $741 | $53 |
| Clindamycin Phosphate | 11 | $389 | $35 |
| Hydroxyzine | 26 | $257 | $10 |
| Triamcinolone Acetonide | 15 | $137 | $9 |
| Doxycycline Hyclate | 14 | $114 | $8 |
2017: 3 drugs
| Hydroxyzine | 12 | $185 | $15 |
| Mupirocin | 16 | $128 | $8 |
| Triamcinolone Acetonide | 12 | $78 | $6 |
2016: 2 drugs
| Clobetasol Propionate | 15 | $1,800 | $120 |
| Triamcinolone Acetonide | 22 | $207 | $9 |
2015: 1 drug
| Clobetasol Propionate | 13 | $2,726 | $210 |
2013: 2 drugs
| Ketoconazole | 27 | $706 | $26 |
| Clobetasol Propionate | 12 | $425 | $35 |
Money from drug and device companies
$1,060 in 2025
| 2025 | 16 | 57 | None | $1,060 |
| 2024 | 10 | 12 | None | $361 |
| 2023 | 2 | 2 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Skyrizi | $174 | 12 payments
|
| Janssen Biotech | Tremfya | $151 | 8 payments
|
| Organon | Vtama | $107 | 9 payments
|
| Genzyme | Dupixent | $107 | 4 payments
|
| Ucb | Bimzelx | $105 | 4 payments
|
| Incyte | Opzelura | $61 | 3 payments
|
See all 57 published payments
| Abbvie | Meals · 2025-12-19 | Skyrizi | $8 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-18 | Jublia | $19 |
| Amgen | Meals · 2025-12-17 | Otezla | $18 |
| Novartis Pharmaceuticals | Meals · 2025-12-11 | Cosentyx | $32 |
| Genzyme | Meals · 2025-12-11 | Dupixent | $16 |
| Genzyme | Meals · 2025-12-09 | Dupixent | $18 |
| Abbvie | Meals · 2025-12-03 | Skyrizi | $18 |
| Organon | Meals · 2025-11-25 | Vtama | $11 |
| Janssen Biotech | Meals · 2025-11-13 | Tremfya | $23 |
| Novartis Pharmaceuticals | Meals · 2025-11-13 | Cosentyx | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-09-25 | Libtayo | $23 |
| Abbvie | Meals · 2025-09-16 | Rinvoq | $17 |
| Janssen Biotech | Meals · 2025-09-12 | Tremfya | $7 |
| Genzyme | Meals · 2025-09-10 | Ayvakit | $37 |
| Incyte | Meals · 2025-09-05 | Opzelura | $16 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $28 |
| Mayne Pharma Commercial | Meals · 2025-09-02 | None | $6 |
| Lilly USA | Meals · 2025-08-28 | None | $26 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $14 |
| Janssen Biotech | Meals · 2025-08-20 | Tremfya | $16 |
| Incyte | Meals · 2025-08-13 | Opzelura | $22 |
| Incyte | Meals · 2025-08-07 | Opzelura | $23 |
| Abbvie | Meals · 2025-07-25 | Skyrizi | $7 |
| Organon | Meals · 2025-07-18 | Vtama | $19 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $3 |
| Kyowa Kirin | Meals · 2025-07-10 | Poteligeo | $24 |
| Ucb | Meals · 2025-07-10 | Bimzelx | $28 |
| Abbvie | Meals · 2025-06-26 | Skyrizi | $13 |
| Regeneron Healthcare Solutions | Meals · 2025-06-19 | Dupixent | $34 |
| Janssen Biotech | Meals · 2025-06-18 | Tremfya | $22 |
| Botanix SB | Meals · 2025-06-17 | Sofdra | $27 |
| Ucb | Meals · 2025-06-13 | Bimzelx | $26 |
| Botanix SB | Meals · 2025-05-14 | Sofdra | $20 |
| Sun Pharmaceutical Industries | Meals · 2025-05-10 | Winlevi | $19 |
| Abbvie | Meals · 2025-05-02 | Skyrizi | $12 |
| Ucb | Meals · 2025-05-01 | Bimzelx | $25 |
| Abbvie | Meals · 2025-04-25 | Botox | $21 |
| Organon | Meals · 2025-03-29 | Vtama | $6 |
| Genzyme | Meals · 2025-03-28 | Dupixent | $35 |
| Organon | Meals · 2025-03-28 | Vtama | $0 |
| Abbvie | Meals · 2025-03-27 | Botox | $27 |
| Galderma Laboratories L.P. | Meals · 2025-03-21 | Nemluvio | $15 |
| Ucb | Meals · 2025-03-20 | Bimzelx | $27 |
| Amgen | Meals · 2025-03-12 | Otezla | $19 |
| Organon | Meals · 2025-03-12 | Vtama | $7 |
| Organon | Meals · 2025-03-06 | Vtama | $15 |
| Abbvie | Meals · 2025-02-20 | Skyrizi | $12 |
| Organon | Meals · 2025-02-20 | Vtama | $17 |
| Galderma Laboratories L.P. | Meals · 2025-02-07 | Aklief | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-02-07 | Winlevi | $15 |
| Organon | Meals · 2025-02-06 | Vtama | $19 |
| Janssen Biotech | Meals · 2025-01-29 | Tremfya | $26 |
| Organon | Meals · 2025-01-29 | Vtama | $12 |
| Janssen Biotech | Meals · 2025-01-17 | Tremfya | $27 |
| Abbvie | Meals · 2025-01-09 | Skyrizi | $16 |
| Abbvie | Education · 2025-01-09 | Skyrizi | $10 |
| Amgen | Meals · 2025-01-09 | Otezla | $19 |
See earlier years (2024, 2023)
2024: $361
| Janssen Biotech | Tremfya | $123 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $59 | 2 payments
|
| Revance Therapeutics | Daxxify | $45 | 1 payment
|
| Abbvie | Rinvoq | $26 | 1 payment
|
| Arcutis Biotherapeutics | Zoryve | $24 | 1 payment
|
| Incyte | Opzelura | $20 | 1 payment
|
| Lilly USA | Taltz | $19 | 1 payment
|
| Amgen | Otezla | $17 | 1 payment
|
| Solta Medical a division of Bausch Health US | Clear+Brilliant | $15 | 1 payment
|
| Pfizer | Eucrisa | $14 | 1 payment
|
2023: $41
| Incyte | Opzelura | $25 | 1 payment
|
| Pfizer | Cibinqo | $15 | 1 payment
|
Professional record
- NPI
- 1386713147
- Licence
- AZ AZ2980, CA 19717California C19717: Cancelled
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
- Mailing address
- 777 Knowles Dr # 16, Los Gatos, CA, 95032
- NPI first listed
- 2006-11-07
- NPI last updated
- 2022-08-08
- NPI record certified
- 2022-08-08
This is when the NPI record was last certified, not a medical board exam.